These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24228413)

  • 1. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; introduction].
    Kimura K; Nagai R
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2284. PubMed ID: 24228413
    [No Abstract]   [Full Text] [Related]  

  • 2. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 1) Overview of guidelines: concepts of making clinical practice guidelines and discussion on their social impacts, (1) Breast cancer practice guideline].
    Nakamura S
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2285-90. PubMed ID: 24228414
    [No Abstract]   [Full Text] [Related]  

  • 3. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 1) Overview of guidelines: concepts of making clinical practice guidelines and discussion on their social impacts. (3) Guideline for managements of hypertension--concept and social significance].
    Shimamoto K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2296-300. PubMed ID: 24228416
    [No Abstract]   [Full Text] [Related]  

  • 4. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 4) Guidelines in Japan and in the world].
    Urashima M
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2313-8. PubMed ID: 24228419
    [No Abstract]   [Full Text] [Related]  

  • 5. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 2) Clinical guidelines and consensus development].
    Fukui T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2301-6. PubMed ID: 24228417
    [No Abstract]   [Full Text] [Related]  

  • 6. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 1) Overview of guidelines: concepts of making clinical practice guidelines and discussion on their social impacts. (2) Evidence-based practical guideline for the treatment of diabetes in Japan].
    Haneda M
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2291-5. PubMed ID: 24228415
    [No Abstract]   [Full Text] [Related]  

  • 7. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 3) Impact, evaluation and legal issues of clinical practice guidelines].
    Shimbo T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2307-12. PubMed ID: 24228418
    [No Abstract]   [Full Text] [Related]  

  • 8. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Panel discussion: Development of a social system for the best medical quality and security; introduction].
    Teramoto T; Kubo K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2319. PubMed ID: 24228420
    [No Abstract]   [Full Text] [Related]  

  • 9. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; introduction].
    Tsubouchi H; Fukuda K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2224. PubMed ID: 24228402
    [No Abstract]   [Full Text] [Related]  

  • 10. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; introduction].
    Akashi K; Ueda T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2254. PubMed ID: 24228407
    [No Abstract]   [Full Text] [Related]  

  • 11. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 2) Clinical application of iPS cells in cardiovascular field].
    Fukuda K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2232-40. PubMed ID: 24228404
    [No Abstract]   [Full Text] [Related]  

  • 12. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 1) Regenerative medicine for digestive organs and kidney].
    Nakauchi H
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2225-31. PubMed ID: 24228403
    [No Abstract]   [Full Text] [Related]  

  • 13. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 3) Regenerative medicine for neurological disorders].
    Takahashi J
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2241-6. PubMed ID: 24228405
    [No Abstract]   [Full Text] [Related]  

  • 14. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Immunity and diseases in internal medicine--Frontier of pathophysiology and treatment; 3) Pathophysiology and the recent treatment of rheumatoid arthritis].
    Fujii T
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2111-5. PubMed ID: 27522760
    [No Abstract]   [Full Text] [Related]  

  • 15. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 4) Perspective on regenerative medicine for spinal cord injury using iPS cell--from bench to bedside].
    Nakamura M; Okano H; Toyama Y
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2247-53. PubMed ID: 24228406
    [No Abstract]   [Full Text] [Related]  

  • 16. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 5) Stem cell disorders and epigenetics].
    Shimono Y
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2279-83. PubMed ID: 24228412
    [No Abstract]   [Full Text] [Related]  

  • 17. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 3) iPS cell technology for neurodegenerative disease].
    Inoue H
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2267-72. PubMed ID: 24228410
    [No Abstract]   [Full Text] [Related]  

  • 18. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 2) Human leukemic stem cell].
    Akashi K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2262-6. PubMed ID: 24228409
    [No Abstract]   [Full Text] [Related]  

  • 19. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 1) Abnormalities in hematopoietic stem cells: congenital immunodeficiencies].
    Hara T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2255-61. PubMed ID: 24228408
    [No Abstract]   [Full Text] [Related]  

  • 20. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Dementia: Concept and Clinical Features in Diabetes-related Dementia].
    Hanyu H
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1901-6. PubMed ID: 30160895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.